4-41746302-G-C
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003924.4(PHOX2B):c.450C>G(p.Arg150Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000745 in 1,613,824 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_003924.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00371 AC: 564AN: 152178Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00105 AC: 261AN: 248300Hom.: 5 AF XY: 0.000831 AC XY: 112AN XY: 134796
GnomAD4 exome AF: 0.000436 AC: 637AN: 1461530Hom.: 7 Cov.: 32 AF XY: 0.000367 AC XY: 267AN XY: 727108
GnomAD4 genome AF: 0.00372 AC: 566AN: 152294Hom.: 5 Cov.: 32 AF XY: 0.00372 AC XY: 277AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:3
- -
PHOX2B: BP4, BP7, BS1 -
Variant summary: The PHOX2B c.450C>G (p.Arg150Arg) variant causes a synonymous change involving a non-conserved nucleotide with 5/5 splice prediction tools calculating no significant effect on splicing, although these predictions have yet to be functionally assessed. This variant was found in the large, broad control population, ExAC, with an allele frequency of 134/117664 (1 homozygote, 1/877, frequency: 0.001139), predominantly observed in the African cohort, 129/9668 (1 homozygote, 1/74, frequency: 0.01334), which significantly exceeds the estimated the maximal expected allele frequency for a pathogenic PHOX2B variant of 1/1250000 (0.0000008). Therefore, suggesting the variant is a common polymorphism found in population(s) of African origin. Therefore, taking all available lines of evidence into consideration, the variant of interest is classified as Benign. -
not specified Benign:2
- -
p.Arg150Arg in exon 3 of PHOX2B: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 1.3% (129/9668) o f African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs17881486). -
Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease Benign:1
- -
Neuroblastoma, susceptibility to, 2;C5562075:Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease Benign:1
- -
Neuroblastoma, susceptibility to, 2 Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Haddad syndrome Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Congenital central hypoventilation Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at